Paper41664086
Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study.
Itani M and 8 others. BMC Urol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study. Papers, record 41664086. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41664086
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Hyperplasia | Major topic |
| Registries | Major topic |
| Clinical Trials as Topic | Major topic |
| Male | |
| Humans |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39036761 | Risks and side effects in the medical management of benign prostatic hyperplasia. | Prostate Int | 2024 | https://conductscience.org/library/papers/39036761 | PubMed |
| 2 | 17947786 | Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. | BMJ | 2007 | https://conductscience.org/library/papers/17947786 | PubMed |
| 3 | 24268083 | Use of interrupted time series analysis in evaluating health care quality improvements. | Acad Pediatr | 2013 | https://conductscience.org/library/papers/24268083 | PubMed |
| 4 | 31492792 | Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications. | BMJ Open | 2019 | https://conductscience.org/library/papers/31492792 | PubMed |
| 5 | 22433036 | A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. | BMC Psychiatry | 2012 | https://conductscience.org/library/papers/22433036 | PubMed |
| 6 | 37094878 | CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials. | BMJ | 2023 | https://conductscience.org/library/papers/37094878 | PubMed |
| 7 | 40211463 | Safety Reporting in Trials on Atrial Fibrillation: An Observational Study of ClinicalTrials.gov Registry and Corresponding Publications. | J Cardiovasc Electrophysiol | 2025 | https://conductscience.org/library/papers/40211463 | PubMed |
| 8 | 25760355 | Compliance with results reporting at ClinicalTrials.gov. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25760355 | PubMed |
| 9 | 19858427 | Adverse events in randomized trials: neglected, restricted, distorted, and silenced. | Arch Intern Med | 2009 | https://conductscience.org/library/papers/19858427 | PubMed |
| 10 | 39915715 | Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications. | BMC Med Res Methodol | 2025 | https://conductscience.org/library/papers/39915715 | PubMed |
| 11 | 15273542 | Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. | Ann Surg | 2004 | https://conductscience.org/library/papers/15273542 | PubMed |
| 12 | 27635471 | Trial Reporting in ClinicalTrials.gov - The Final Rule. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27635471 | PubMed |
| 13 | 24311990 | Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. | PLoS Med | 2013 | https://conductscience.org/library/papers/24311990 | PubMed |
| 14 | 24323037 | Adverse event reporting in cancer clinical trial publications. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24323037 | PubMed |
| 15 | 39533030 | Safety reporting in trials on glaucoma interventions registered in ClinicalTrials.gov and corresponding publications. | Sci Rep | 2024 | https://conductscience.org/library/papers/39533030 | PubMed |
| 16 | 19901971 | Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. | PLoS Med | 2009 | https://conductscience.org/library/papers/19901971 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41664086
GET https://conductscience.org/api/papers/v1/41664086/authors